1. Circulating Glioma Biomarkers: Agents of Detection

    High-grade gliomas represent one of the most aggressive and treatment-resistant types of human brain cancer, with a median survival rate of only 14.6 months for patients with grade IV glioma (glioblastoma) [1,2].
  2. Exosome Biomarker for Alzheimer's Disease

    Alzheimer’s disease is a neurodegenerative disorder, involving memory loss which progressively worsens, eventually leading to death. Currently there is no cure and diagnosis is commonly based on a person’s family history or expensive and intrusive detection methods.
  3. Cellular Exosomes for the 21st Century - Overview - part 1

    Discovered nearly 30 years ago, exosomes are now being implicated in one of the most important and promising breakthroughs in medical therapy yet. A quick glance in PubMed reveals over ~3,000 journal references since their discovery in 1983.

3 Item(s)

To Top